The paper presents an analysis of 14317 world papers in celiac disease, retrieved from Scopus database for the period 2005-14, experiencing an annual average growth rate of 5.20% and citation impact of 12.53.The 15 most productive countries account for 83.89% share in world output, with largest share (21.40%) coming from U.S.A, followed by Italy (12.61%), U.K. (8.23%), Germany (5.41%) etc., during 2005-14. U.S.A achieved the global citation share (35.13%) followed by Italy (17.16%), U.K. (15.74%) etc. Medicine registered the highest publication share (87.93%), followed by biochemistry, genetics and molecular biology (13.56%), immunology and microbiology (6.73%), agricultural and biological sciences, (5.57%), nursing (3.07%), pharmacology, toxicology and pharmaceutics (2.74%), neurosciences (2.26%), etc. Diarrhoea contributed the largest share (8.10%) in publications by symptoms during 2005-14, followed by abdominal pain (7.68%), insulin dependent diabetes mellitus (6.84%), Crohn disease (6.22%), enteritis (5.34%), etc. Gluten free diet contributed the largest share (18.47%) among significant keywords. The 15 most productive organisations, authors and journals accounted for 15.06%, 10.71% and 16.57% share of the world publication output respectively during 2005-14. It is concluded that individual countries must foster global research and development, by way of providing increased investment in R and D and increase their specialized manpower and provide adequate training courses and infrastructural facilities to scientists and researchers to control the challenges faced by the spread of this disease.